Mull; Eric
Patent Applications and Registrations
Patent applications and USPTO patent grants for Mull; Eric.The latest application filed is for "indazole derivatives as alpha v integrin antagonists".
Company Profile
8.28.31
- Mull; Eric - Guilford CT
- Mull; Eric - Gullford CT
Patent Activity
| Patent | Date |
|---|---|
| Immunomodulators acting as antagonists of PD-1 Grant 11,066,445 - Gillman , et al. July 20, 2 | 2021-07-20 |
| Indazole derivatives as alpha v integrin antagonists Grant 11,028,071 - Ye , et al. June 8, 2 | 2021-06-08 |
| Indazole Derivatives As Alpha V Integrin Antagonists App 20200339540 - Ye; Xiang-Yang ; et al. | 2020-10-29 |
| Compounds useful as immunomodulators Grant 10,745,382 - Yeung , et al. A | 2020-08-18 |
| Indazole derivatives as .alpha.v integrin antagonists Grant 10,745,384 - Ye , et al. A | 2020-08-18 |
| Immunomodulators Acting As Antagonists Of Pd-1 App 20200172578 - GILLMAN; Kevin W. ; et al. | 2020-06-04 |
| Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 10,538,555 - Miller , et al. Ja | 2020-01-21 |
| Immunomodulators Grant 10,450,347 - Miller , et al. Oc | 2019-10-22 |
| Indazole Derivatives As Alpha V Integrin Antagonists App 20190256496 - Ye; Xiang-Yang ; et al. | 2019-08-22 |
| Immunomodulators Grant 10,358,463 - Miller , et al. | 2019-07-23 |
| Compounds useful as immunomodulators Grant 10,144,706 - Yeung , et al. De | 2018-12-04 |
| Immunomodulators Grant 10,143,746 - Allen , et al. De | 2018-12-04 |
| Immunomodulators Grant 9,944,678 - Sun , et al. April 17, 2 | 2018-04-17 |
| Compounds Useful As Immunomodulators App 20180057455 - YEUNG; KAP-SUN ; et al. | 2018-03-01 |
| Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 9,879,046 - Miller , et al. January 30, 2 | 2018-01-30 |
| Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20170369530 - Miller; Michael Matthew ; et al. | 2017-12-28 |
| Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 9,850,283 - Miller , et al. December 26, 2 | 2017-12-26 |
| Immunomodulators App 20170283463 - Miller; Michael Matthew ; et al. | 2017-10-05 |
| Immunomodulators App 20170283462 - Miller; Michael Matthew ; et al. | 2017-10-05 |
| Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20170260237 - Miller; Michael Matthew ; et al. | 2017-09-14 |
| Immunomodulators App 20170252432 - Allen; Martin Patrick ; et al. | 2017-09-07 |
| Immunomodulators Grant 9,732,119 - Sun , et al. August 15, 2 | 2017-08-15 |
| Compounds Useful As Immunomodulators App 20170107202 - YEUNG; KAP-SUN ; et al. | 2017-04-20 |
| Macrocyclic compounds as HCV entry inhibitors Grant 9,624,245 - Wang , et al. April 18, 2 | 2017-04-18 |
| Hepatitis C virus inhibitors Grant 9,598,433 - Sun , et al. March 21, 2 | 2017-03-21 |
| Hepatitis C virus inhibitors Grant 9,527,885 - Hiebert , et al. December 27, 2 | 2016-12-27 |
| Macrocyclic Inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 Protein/Protein Interactions App 20160340391 - Miller; Michael Matthew ; et al. | 2016-11-24 |
| Hepatitis C virus inhibitors Grant 9,499,550 - Sun , et al. November 22, 2 | 2016-11-22 |
| Immunomodulators App 20160272680 - Boy; Kenneth M. ; et al. | 2016-09-22 |
| Immunomodulators App 20160222060 - Miller; Michael Matthew ; et al. | 2016-08-04 |
| Immunomodulators App 20160175386 - Mapelli; Claudio ; et al. | 2016-06-23 |
| Immunomodulators App 20160176928 - Sun; Li-Qiang ; et al. | 2016-06-23 |
| Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20160158349 - Miller; Michael Matthew ; et al. | 2016-06-09 |
| Immunomodulators App 20160137696 - Gillman; Kevin W. ; et al. | 2016-05-19 |
| Immunomodulators App 20160102122 - Sun; Li-Qiang ; et al. | 2016-04-14 |
| Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions Grant 9,308,236 - Miller , et al. April 12, 2 | 2016-04-12 |
| Macrocyclic Compounds As Hcv Entry Inhibitors App 20150368267 - WANG; Tao ; et al. | 2015-12-24 |
| Hepatitis C Virus Inhibitors App 20150284391 - Sun; Li-Qiang ; et al. | 2015-10-08 |
| Hepatitis C Virus Inhibitors App 20150284409 - Sun; Li-Qiang ; et al. | 2015-10-08 |
| Hepatitis C Virus Inhibitors App 20150125422 - Hiebert; Sheldon ; et al. | 2015-05-07 |
| Hepatitis C virus inhibitors Grant 8,957,203 - Hiebert , et al. February 17, 2 | 2015-02-17 |
| Macrocyclic Inhibitors Of The Pd-1/pd-l1 And Cd80(b7-1)/pd-l1 Protein/protein Interactions App 20140294898 - Miller; Michael Matthew ; et al. | 2014-10-02 |
| Compounds for the treatment of hepatitis C Grant 8,765,944 - Sun , et al. July 1, 2 | 2014-07-01 |
| Compounds for the treatment of hepatitis C Grant 8,741,884 - Wang , et al. June 3, 2 | 2014-06-03 |
| Compounds for the treatment of hepatitis C Grant 8,586,584 - Wang , et al. November 19, 2 | 2013-11-19 |
| Compounds for the treatment of hepatitis C Grant 8,445,490 - Wang , et al. May 21, 2 | 2013-05-21 |
| Hepatitis C Virus Inhibitors App 20130115190 - Hiebert; Sheldon ; et al. | 2013-05-09 |
| Compounds for the Treatment of Hepatitis C App 20120213729 - Sun; Li-Qiang ; et al. | 2012-08-23 |
| Compounds for the Treatment of Hepatitis C App 20120093767 - Wang; Tao ; et al. | 2012-04-19 |
| Compounds for the Treatment of Hepatitis C App 20120093766 - Wang; Tao ; et al. | 2012-04-19 |
| Compounds for the Treatment of Hepatitis C App 20110086858 - Wang; Tao ; et al. | 2011-04-14 |
| Pyrimidine Derivatives App 20090258888 - Nagarathnam; Dhanapalan ; et al. | 2009-10-15 |
| Indane amides App 20090247590 - Wang; Yamin ; et al. | 2009-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 